APD
62
5
RF
51
-2
TROW
59
-2
MAS
63
-5
HAL
47
3
TEL
86
-2
PNR
65
-4
CMA
50
-5
EQIX
57
-2
DO
83
2
UPS
55
4
AMAT
60
-3
HBAN
54
-3
SLG
64
-2
MPC
41
2
MAC
77
2
BMY
33
-2
PG
63
2
AON
28
3
AEE
41
-2
APD
62
5
RF
51
-2
TROW
59
-2
MAS
63
-5
HAL
47
3
TEL
86
-2
PNR
65
-4
CMA
50
-5
EQIX
57
-2
DO
83
2
UPS
55
4
AMAT
60
-3
HBAN
54
-3
SLG
64
-2
MPC
41
2
MAC
77
2
BMY
33
-2
PG
63
2
AON
28
3
AEE
41
-2
Financhill
Back

Bausch Health Companies Quote, Financials, Valuation and Earnings

Sell
20

BHC
Bausch Health Companies

Last Price:
6.95
Seasonality Move:
2.87%

7 Day Trial

ALL ACCESS PASS

$ 7

Bausch Health Companies Price Quote

$6.95
-0.12 (-1.7%)
(Updated: May 17, 2024 at 10:20 AM ET)

Bausch Health Companies Key Stats

Sell
20
Bausch Health Companies (BHC) is a Sell
Day range:
$7.00 - $7.14
52-week range:
$6.53 - $11.46
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.29
P/B ratio:
0%
Volume:
1.9M
Avg. volume:
3.8M
1-year change:
17.44%
Market cap:
$2.6B
Revenue:
$8.8B
EPS:
$-1.24

How Much Does Bausch Health Companies Make?

Is Bausch Health Companies Growing As A Company?

Bausch Health Companies Stock Price Performance

What Is Bausch Health Companies 52-Week High & Low?

Bausch Health Companies Price To Free Cash Flow

Is It Risky To Buy Bausch Health Companies?

Is Bausch Health Companies Cash Flow Positive?

  • What Is BHC Cash Flow From Operations?
    Cash flow from operations (TTM) is $1.1B
  • What Is Bausch Health Companies’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $1.3B
  • What Is Bausch Health Companies’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$2.1B

Bausch Health Companies Return On Invested Capital

  • Is Management Doing A Good Job?
    BHC return on invested capital is -2.11%
  • What Is Bausch Health Companies Return On Assets?
    ROA measures how assets are converting to revenues and is -1.72%
  • What Is BHC Return On Equity?
    ROE is a measure of profitability and is 0%

Bausch Health Companies Earnings Date & Stock Price

Bausch Health Companies Competitors

Bausch Health Companies Dividend Yield

Data Unavailable

Bausch Health Companies Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -17.83%
Revenue: 10.75% -0.44%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 6
Sell Recommendations: 0
Price Target: 9.79
Upside from Last Price: 38.41%

Major Shareholders

  • How many BHC shares are owned by institutional investors?
    4.4B BHC shares are owned by institutional investors
  • How many BHC shares are owned by insiders?
    12.4M BHC shares are owned by insiders